Pia Krause Møller (@krause_moeller) 's Twitter Profile
Pia Krause Møller

@krause_moeller

Clinical Researcher, PhD, at the Department of Oncology (Radiotherapy section) @OncoCareOUH 👩‍⚕️#PatientReportedOutcome

ID: 998888642629263360

calendar_today22-05-2018 11:29:45

85 Tweet

75 Followers

125 Following

Tipsro Tweets (@tipsrotweets) 's Twitter Profile Photo

Happy #InternationalWomensDay to our fabulous authors, reviewers and editorial board members. We couldn’t do it without you! Thank you 🙏 #radonc #radther @OncologyAdvance ESTRO @LeechmMichelle

PRO ON (@pro_on_dk) 's Twitter Profile Photo

Keep an eye on Cecilie Holländer-Mieritz - her PhDthesis ‘Patient-Generated Health Data in Head and Neck Cancer’ contains possible solutions for future health care. Rigshospitalet #Fremtidsdage

Keep an eye on <a href="/CecilieHMieritz/">Cecilie Holländer-Mieritz</a> - her PhDthesis ‘Patient-Generated Health Data in Head and Neck Cancer’ contains possible solutions for future health care.
<a href="/Rigshospitalet/">Rigshospitalet</a>
#Fremtidsdage
Pia Krause Møller (@krause_moeller) 's Twitter Profile Photo

Today at ESTRO, a very nice presentation by Mette Felter on some of our first data from the SOFT-trial - MR-guided SABR for oligometastases. Results of a great multinational collaboration! DCCC_Radiotherapy Gitte Persson Onkologisk Afdeling, OUH

Today at ESTRO, a very nice presentation by <a href="/FelterMette/">Mette Felter</a> on some of our first data from the SOFT-trial - MR-guided SABR for oligometastases. Results of a great multinational collaboration! <a href="/DCCC_RT/">DCCC_Radiotherapy</a> <a href="/GittePersson/">Gitte Persson</a> <a href="/onko_ouh/">Onkologisk Afdeling, OUH</a>
Pia Krause Møller (@krause_moeller) 's Twitter Profile Photo

Great 1st day: ePRO on #ESMO2023 with Ethan Basch presenting final results of the PRO-TECT trial. No benefit in OS for patients with metastatic disease but effect of ePRO on QoL and symptoms - important discussion of meaningful endpoints PRO ON Onkologisk Afdeling R, OUH Christina Ruhlmann

Great 1st day: ePRO on #ESMO2023 with Ethan Basch presenting final results of the PRO-TECT trial. No benefit in OS for patients with metastatic disease but effect of ePRO on QoL and symptoms - important discussion of meaningful endpoints <a href="/PRO_ON_Dk/">PRO ON</a> <a href="/OncoCareOUH/">Onkologisk Afdeling R, OUH</a> <a href="/RuhlmannC/">Christina Ruhlmann</a>
Pia Krause Møller (@krause_moeller) 's Twitter Profile Photo

Impressive data from the NARLAL2 study very nicely presented by Tine Schytte at #ESTRO2024: Higher locoregional control but not higher toxicity when doseescalating lung cancer RT Onkologisk Afdeling, OUH DCCC_Radiotherapy

Impressive data from the NARLAL2 study very nicely presented by <a href="/TineSchytte/">Tine Schytte</a> at #ESTRO2024: Higher locoregional control but not higher toxicity when doseescalating lung cancer RT <a href="/onko_ouh/">Onkologisk Afdeling, OUH</a> <a href="/DCCC_RT/">DCCC_Radiotherapy</a>
Yat Tsang (@yattsang) 's Twitter Profile Photo

A great way to connect with #RadiationTherapist from all over 🌎 through ESTRO #RTT workshops on topics covering #RTT Research Practice, Recruitment and Retention, and the Future roles/Career progression! SCoR Members CAMRT/ACTRM @ASMIRTorg Iirrt APRTiCoP come to join us!